Skip to content

ASP6025 S 120V/50-60Hz 000000014049559068Recalls & reported problems

Leica Biosystems Nussloch GmbH · The ASP6025 S Tissue Processor is a modular tissue processor for the following laboratory applications: • Fixation • Dehydration • Infiltration with intermedium • Paraffin infiltration of histological tissue specimens. The ASP6025 S can be used as medical IVD product. The improved features of the ASP6025 S are the combination of: • Reduced processing time • Easier reagent exchange • Monitoring the ethanol quality by density measurement as well as the • Ability to replace xylene, a substance that is hazardous (including to the health), with special process protocols. The instrument has been designed so that it is safe to use by the operator as well as for processing specimens. However, the prerequisite for this is that it is operated according to these Instructions for Use. · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04049188210784), received between Sep 11, 2025 and Sep 11, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Device Ingredient or Reagent Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Ingredient or Reagent Problem1

Patient problems

  • Unspecified Tissue Injury1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjurySep 11, 2025Device Ingredient or Reagent Problem; Device Ingredient or Reagent Problem

    ON (B)(6), A CUSTOMER NOTIFIED LEICA BIOSYSTEMS THAT THEIR "ROTINA NOTURNA" PROCESSING PROTOCOL, WHICH BEGAN ON (B)(6) AND ENDED AT 10:16 AM ON (B)(6), PRESENTED A QUALITY DEVIATION. PRIOR AND SUBSEQUENT PROCESSING DID NOT PRESENT ANY ISSUES. THE TISSUE SAMPLES PROCESSED IN THE AFFECTED RUN WERE ALL LARGE TISSUE SAMPLES. ON (B)(6), LEICA BIOSYSTEMS NUSSLOCH GMBH WAS INFORMED THAT ONE TISSUE SAMPLE COULD NOT BE DIAGNOSED, REQUIRING THE PATIENT CONCERNED TO UNDERGO A RE-BIOPSY.

    Patient problems: Unspecified Tissue Injury

    MAUDE report 23023743 ↗

Other PROCESSOR, TISSUE, AUTOMATED devices

All PROCESSOR, TISSUE, AUTOMATED devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page